Yabao Pharmaceutical Group Co. Ltd.SSE: 600351

Announcement on Share Repurchase Plan through Call Auction and the Repurchase Report

· Issued by Yabao Pharmaceutical Group Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · · 6 pages · Chinese

Summary by 6ix AI

Yabao Pharmaceutical Group Co. Ltd. has announced a share repurchase plan through a call auction, detailing the purpose and procedures for the buyback. The plan aims to repurchase shares to enhance shareholder value and will utilize the company's own funds, with a specified price limit for the shares. The repurchase is subject to approval by the company's shareholders and is expected to be completed within a year after approval. The filing also outlines potential risks associated with the buyback, including the need for creditor consent and market conditions affecting the share price.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Share Repurchase Plan through Call Auction and the Repurchase Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Yabao Pharmaceutical Group Co. Ltd. on 6ix

Earlier from Yabao Pharmaceutical

Later from Yabao Pharmaceutical

All Yabao Pharmaceutical news releases